所属地区: --
所属机构: --
抱歉,该信息暂无中文翻译信息,为您显示项目原文信息。
Published date: 19 June 2024
Open future opportunity - This means that the buyer is not yet ready to invite bid applications but early notification has been provided and some dialogue may be possible.
Data capture services - 72313000
England
£0
VDS PoC FY25/26
19 June 2024
27 June 2024
1 April 2025
31 March 2026
Restricted procedure (above threshold)
A two-stage procedure, where the first stage is used to select suppliers, who are then invited to bid in the second stage.
This procedure can be used for procurements above the relevant contract value threshold.
Yes
No
This procurement will provide opportunity to contract for Point of Care data capture & flow services during the period until the PCSS framework is awarded.
1. Market Engagement Session is planned for 27 Jun 2024
2. Publication of Contract Notice and procurement documents will be via Find a Tender, planned for 12 Jul 2024
3. The supplier shall submit its Request to Participate via the e-Portal (to be notified) no later than CoB 5 Aug 2024
4. NHSE qualification of each supplier's Request to Participate will be made on the basis of meeting the self-certification criteria against system specifications (to be notified).
Any negative responses will result in the supplier not qualifying for progression to full submission and subsequent assurance phases.
5. All qualifying suppliers will receive subsequent Invitation to Tender.
Invitation is expected to be issued by CoB 14 Aug 2024.
Under the ITT, all invited suppliers will be required to self-certify that they meet the following Award Criteria:
o 100% of "MUST" requirements defined in the Overall Non-Functional Requirements for VDS System Providers v1.
o 100% of "MUST" requirements defined in the Overall Functional Capabilities for Vaccine Data Capture and Flow v1.
In addition, the supplier will be asked as a pass / fail requirement to confirm that it:
o Meets 100% of the requirements defined in the current DCB0129 Clinical specification.
o Accepts in full, the contract terms & commercial conditions.
o Confirms that it will, when requested to do so:
Onboard any Section 7a vaccine types that NHSE may require to service towards vaccine agnostic operations.
Confirms commitment to provide all requested resources and effort to progress the assurance, and
Provide any documentation and/or proofs to evidence its self-certification against the requirements (as below) that may include submission of and assessment on the following:
--- Copy of the terms under which the supplier's service recipients (community pharmacies) are engaged, including supplier's data policy.
--- Clinical Hazard logs
--- Clinical Safety Report
--- Clinical Front-end data capture
--- Data flows for additional information - FLU & COVID only, and
--- Any further self-assessment documentation and/or check-list that may be required eg. capability to integrate with the IMS FHIR API
The supplier must also confirm that it will provide both video proofs with vocalised commentary and associated data files, and will attend live-virtual presentation sessions to demo system capabilities.
6. Supplier submissions must be received by NHSE no later than CoB 13 Sept 2024 to qualify
7. NHSE validation of supplier submissions will occur 16-28 Sept 2024
8. All qualifying suppliers will be taken through to assurance which will operate 30 Sept 2024 to 14 Feb 2025
9. The Stand-Still period will operate between 17-26 Feb 2025
10. Contracts will be awarded to all qualifying and fully assured suppliers by 3 Mar 2025
Financial year | Budget |
---|---|
2025/2026 | £5,000,000 |
Follow the instructions given in the description or the more information section.
Victoria Barker-Smith
Wellington House,133-155 Waterloo Road
LONDON
SE16LH
England
020 7333 6154
Is there anything wrong with this page?
本网站为您提供准确和及时的招投标信息,但招投标信息存在着变更的可能,请您务必在交易前向招标代理机构或招标人咨询投标详细要求,有关招标的具体要求及情况以招标代理机构或招标人的解释为准。
如果您对这篇招标信息有任何补充或修改建议,请告知我们。
猜你喜欢